It has also been implicated in bladder cancer, with one study finding a correlation between EZH2 overexpression and non-muscle invasive bladder cancer (NMIBC) in both mouse models and humans, as well as an increased likelihood of disease recurrence in those with EZH2 overexpression [22]. Here, EZH2 is linked to urinary bladder carcinoma.